Wanner C - Search Results

1

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.

Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H. Drechsler C, et al. Among authors: wanner c. Transplantation. 2015 Jul;99(7):1470-6. doi: 10.1097/TP.0000000000000568. Transplantation. 2015. PMID: 25675199 Clinical Trial.

2

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

Wanner C, Metzger T. Wanner C, et al. Nephrol Dial Transplant. 2002;17 Suppl 8:29-32; discussion 39-40. doi: 10.1093/ndt/17.suppl_8.29. Nephrol Dial Transplant. 2002. PMID: 12147774 Review.

3

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics.

Wanner C, Krane V, März W, Olschewski M, Asmus HG, Krämer W, Kühn KW, Kütemeyer H, Mann JF, Ruf G, Ritz E; Deutsche Diabetes-Dialyse-Studie (4D) Study Group. Wanner C, et al. Kidney Blood Press Res. 2004;27(4):259-66. doi: 10.1159/000080241. Epub 2004 Aug 16. Kidney Blood Press Res. 2004. PMID: 15316128 Clinical Trial.

4

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators. Wanner C, et al. N Engl J Med. 2005 Jul 21;353(3):238-48. doi: 10.1056/NEJMoa043545. N Engl J Med. 2005. PMID: 16034009 Free article. Clinical Trial.

5

The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.

Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J. Holdaas H, et al. Among authors: wanner c. Int J Cardiol. 2007 Apr 12;117(1):64-74. doi: 10.1016/j.ijcard.2006.06.003. Epub 2006 Aug 4. Int J Cardiol. 2007. PMID: 16889855 Review.

6

The renal safety profile of fluvastatin: results of a pooled analysis.

Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J. Holdaas H, et al. Among authors: wanner c. Ren Fail. 2006;28(6):487-92. doi: 10.1080/08860220600781260. Ren Fail. 2006. PMID: 16928618

7

Dyslipidemia, inflammation and dialysis outcomes: what we know now.

Krane V, Drechsler C, Wanner C. Krane V, et al. Among authors: wanner c. Curr Opin Nephrol Hypertens. 2006 Nov;15(6):566-70. doi: 10.1097/01.mnh.0000247501.41420.dd. Curr Opin Nephrol Hypertens. 2006. PMID: 17053468 Review.

8

Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.

Wanner C, Drechsler C, Krane V. Wanner C, et al. J Ren Nutr. 2007 Jan;17(1):75-8. doi: 10.1053/j.jrn.2006.10.012. J Ren Nutr. 2007. PMID: 17198938 Review.

9

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.

Krane V, Krieter DH, Olschewski M, März W, Mann JF, Ritz E, Wanner C. Krane V, et al. Among authors: wanner c. Am J Kidney Dis. 2007 Feb;49(2):267-75. doi: 10.1053/j.ajkd.2006.11.026. Am J Kidney Dis. 2007. PMID: 17261429

10

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.

Winkler K, Wanner C, Drechsler C, Lilienthal J, März W, Krane V; German Diabetes and Dialysis Study Investigators. Winkler K, et al. Among authors: wanner c. Eur Heart J. 2008 Sep;29(17):2092-9. doi: 10.1093/eurheartj/ehn278. Epub 2008 Jul 9. Eur Heart J. 2008. PMID: 18617483 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,012 results

Search Page